PURPOSE: We hypothesized that post-myocardial ischemia-reperfusion (I/R) remodeling associated matrix metalloproteinase-2 (MMP(2)) activation could be detected by using novel MMP(2) targeted ultrasound imaging. PROCEDURES: We study the combination of MMP(2)-targeted microbubbles (TMB(2)) and control microbubbles with myocardium in 1 week post-I/R rats. RESULTS: In in vitro studies, TMB(2) significantly bound within the risk area (RA) of 1-week post-I/R myocardial sections while rare binding was observed in the control area (CA). In in vivo studies, increased focal retention of TMB(2) was observed within the RA, with the higher myocardial video intensity (RA 42.85 ± 20.12 dB versus CA 25.85 ± 13.40 dB, p < 0.01). However, there was no difference of control microbubble retention in both CA and RA. CONCLUSIONS: A targeted ultrasound contrast imaging approach that employs novel TMB(2) has the potential to provide a less-invasive, higher-resolution technique for in vivo localization of MMP(2) activation and tracking of MMP-mediated post-I/R remodeling.
PURPOSE: We hypothesized that post-myocardial ischemia-reperfusion (I/R) remodeling associated matrix metalloproteinase-2 (MMP(2)) activation could be detected by using novel MMP(2) targeted ultrasound imaging. PROCEDURES: We study the combination of MMP(2)-targeted microbubbles (TMB(2)) and control microbubbles with myocardium in 1 week post-I/R rats. RESULTS: In in vitro studies, TMB(2) significantly bound within the risk area (RA) of 1-week post-I/R myocardial sections while rare binding was observed in the control area (CA). In in vivo studies, increased focal retention of TMB(2) was observed within the RA, with the higher myocardial video intensity (RA 42.85 ± 20.12 dB versus CA 25.85 ± 13.40 dB, p < 0.01). However, there was no difference of control microbubble retention in both CA and RA. CONCLUSIONS: A targeted ultrasound contrast imaging approach that employs novel TMB(2) has the potential to provide a less-invasive, higher-resolution technique for in vivo localization of MMP(2) activation and tracking of MMP-mediated post-I/R remodeling.
Authors: Patricia A Schumann; Jonathan P Christiansen; Rachel M Quigley; Thomas P McCreery; Robert H Sweitzer; Evan C Unger; Jonathan R Lindner; Terry O Matsunaga Journal: Invest Radiol Date: 2002-11 Impact factor: 6.016
Authors: Esther E J M Creemers; Jeniffer N Davis; Andrea M Parkhurst; Peter Leenders; Kathryn B Dowdy; Elizabeth Hapke; Anne M Hauet; Patricia G Escobar; Jack P M Cleutjens; Jos F M Smits; Mat J A P Daemen; Michael R Zile; Francis G Spinale Journal: Am J Physiol Heart Circ Physiol Date: 2002-09-26 Impact factor: 4.733
Authors: A Ducharme; S Frantz; M Aikawa; E Rabkin; M Lindsey; L E Rohde; F J Schoen; R A Kelly; Z Werb; P Libby; R T Lee Journal: J Clin Invest Date: 2000-07 Impact factor: 14.808
Authors: Gregory E R Weller; Michael K K Wong; Ruth A Modzelewski; Erxiong Lu; Alexander L Klibanov; William R Wagner; Flordeliza S Villanueva Journal: Cancer Res Date: 2005-01-15 Impact factor: 12.701
Authors: Gregory E R Weller; Erxiong Lu; Melissa M Csikari; Alexander L Klibanov; David Fischer; William R Wagner; Flordeliza S Villanueva Journal: Circulation Date: 2003-06-30 Impact factor: 29.690
Authors: Howard Leong-Poi; Jonathan Christiansen; Alexander L Klibanov; Sanjiv Kaul; Jonathan R Lindner Journal: Circulation Date: 2003-01-28 Impact factor: 29.690